Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mahoney

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Oncotarget|February 27, 2016
c-Src/Cav1-dependent activation of the EGFR by Dsg2Andrew M Overmiller, Kathleen P McGuinn, Brett J Roberts, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Tumor microenvironment governs the prognostic landscape of immunotherapy for head and neck squamous cell carcinoma: A computational model-guided analysisPriyan Bhattacharya, Alban Linnenbach, Andrew P South, et al.
Frontiers in Oncology|January 8, 2024
Desmoglein-2 as a cancer modulator: friend or foe?Kay K Myo Min, Charlie B Ffrench, Barbara J McClure, et al.
Plos Computational Biology|June 3, 2025
Tumor microenvironment governs the prognostic landscape of immunotherapy for head and neck squamous cell carcinoma: A computational model-guided analysisPriyan Bhattacharya, Alban Linnenbach, Andrew P South, et al.
Differentiation; Research in Biological Diversity|December 21, 2004
Differential structural properties and expression patterns suggest functional significance for multiple mouse desmoglein 1 isoformsDonna Brennan, Ying Hu, Ana Kljuic, et al.
The Journal of Investigative Dermatology|November 20, 2009
Compound heterozygous desmoplakin mutations result in a phenotype with a combination of myocardial, skin, hair, and enamel abnormalitiesMy G Mahoney, Sara Sadowski, Donna Brennan, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 28, 2022
Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathwayXiang Li, Shaomin Wang, Wei Mu, et al.
Iscience|January 1, 2024
A desmosomal cadherin controls multipotent hair follicle stem cell quiescence and orchestrates regeneration through adhesion signalingWilliam V J Hariton, Katja Schulze, Siavash Rahimi, et al.
Frontiers in Oncology|July 3, 2024
Altered extracellular matrix correlates with an immunosuppressive tumor microenvironment and disease progression in younger adults with oral cavity squamous cell carcinomaLeonard E Estephan, Gaurav Kumar, Matthew Stewart, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 26, 2017
Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytesAndrew M Overmiller, Jennifer A Pierluissi, Peter J Wermuth, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Oncotarget|February 27, 2016
c-Src/Cav1-dependent activation of the EGFR by Dsg2Andrew M Overmiller, Kathleen P McGuinn, Brett J Roberts, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Tumor microenvironment governs the prognostic landscape of immunotherapy for head and neck squamous cell carcinoma: A computational model-guided analysisPriyan Bhattacharya, Alban Linnenbach, Andrew P South, et al.
Frontiers in Oncology|January 8, 2024
Desmoglein-2 as a cancer modulator: friend or foe?Kay K Myo Min, Charlie B Ffrench, Barbara J McClure, et al.
Plos Computational Biology|June 3, 2025
Tumor microenvironment governs the prognostic landscape of immunotherapy for head and neck squamous cell carcinoma: A computational model-guided analysisPriyan Bhattacharya, Alban Linnenbach, Andrew P South, et al.
Differentiation; Research in Biological Diversity|December 21, 2004
Differential structural properties and expression patterns suggest functional significance for multiple mouse desmoglein 1 isoformsDonna Brennan, Ying Hu, Ana Kljuic, et al.
The Journal of Investigative Dermatology|November 20, 2009
Compound heterozygous desmoplakin mutations result in a phenotype with a combination of myocardial, skin, hair, and enamel abnormalitiesMy G Mahoney, Sara Sadowski, Donna Brennan, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 28, 2022
Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathwayXiang Li, Shaomin Wang, Wei Mu, et al.
Iscience|January 1, 2024
A desmosomal cadherin controls multipotent hair follicle stem cell quiescence and orchestrates regeneration through adhesion signalingWilliam V J Hariton, Katja Schulze, Siavash Rahimi, et al.
Frontiers in Oncology|July 3, 2024
Altered extracellular matrix correlates with an immunosuppressive tumor microenvironment and disease progression in younger adults with oral cavity squamous cell carcinomaLeonard E Estephan, Gaurav Kumar, Matthew Stewart, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 26, 2017
Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytesAndrew M Overmiller, Jennifer A Pierluissi, Peter J Wermuth, et al.
Pageof 11